Literature DB >> 21643806

18F-FDG uptake in primary lung cancer as a predictor of intratumoral vessel invasion.

Tetsuya Ishibashi1, Mitsuhito Kaji, Tatsuya Kato, Keidai Ishikawa, Masatoshi Kadoya, Nagara Tamaki.   

Abstract

OBJECTIVE: This study investigated how fluorodeoxyglucose (FDG) uptake on PET in the primary tumor may predict intratumoral vessel invasion (IVI) in it.
METHODS: A total of 512 patients with lung neoplasms determined by a surgical procedure and histopathological diagnosis had undergone FDG-PET scanning.
RESULTS: Among the 440 cases confirmed to be malignant, the maximum standardized uptake value (SUV(max)) was significantly lower in IVI-negative cases than IVI-positive cases (P < 0.001). In the substudy on adenocarcinoma (AC), SUV(max) was significantly lower in IVI-negative cases too (P < 0.001), but SUV(max) in squamous cell carcinoma was without significant difference. In addition, IVI was associated with a significantly higher probability of lymph node metastasis (P < 0.001).
CONCLUSIONS: This study indicates that a malignant lung tumor with higher SUV(max) has a significantly higher probability of IVI and lymph node metastasis, particularly if the malignancy is an AC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643806     DOI: 10.1007/s12149-011-0502-2

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  2 in total

1.  Prediction of pathologic prognostic factors in patients with lung adenocarcinomas: comparison of thin-section computed tomography and positron emission tomography/computed tomography.

Authors:  Shingo Iwano; Mariko Kishimoto; Shinji Ito; Katsuhiko Kato; Rintaro Ito; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2014-04-22       Impact factor: 3.909

2.  The correlation of SUVmax with pathological characteristics of primary tumor and the value of Tumor/ Lymph node SUVmax ratio for predicting metastasis to lymph nodes in resected NSCLC patients.

Authors:  Deniz Koksal; Funda Demirag; Hulya Bayiz; Ozlem Ozmen; Ebru Tatci; Bahadir Berktas; Koray Aydoğdu; Erdal Yekeler
Journal:  J Cardiothorac Surg       Date:  2013-04-04       Impact factor: 1.637

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.